Arotech Corp (NQ: ARTX )

2.995 USD UNCHANGED

Last Price Updated: 4:00 PM EST, Dec 18, 2019 Add to My Watchlist

Price and Volume

Volume	0
Open	2.995
Bid (Size)	2.990 (1,550)
Ask (Size)	3.990 (1)
Prev. Close	2.995
Today's Range	2.995 - 2.995
52wk Range	2.980 - 3.000
Shares Outstanding	26,498,862
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Moore Kuehn, PLLC Encourages Investors of SRC Energy, Inc. (SRCI), Achillion Pharmaceuticals, Inc. (ACHN), and Arotech Corporation (ARTX) to Contact Firm

November 22, 2019

Moore Kuehn, PLLC, a securities law firm located on Wall Street in downtown New York City, is investigating potential claims involving the directors and officers regarding possible breaches of...

Nanopositioning Systems Market Analysis On Size and Industry Demand 2020: Aerotech Inc (ARTX)., Prior Scientific Instruments, Physik Instrumente (PI) GmbH & Co (ETR: SGF)

September 11, 2020

Performance

YTD	N/A	N/A
1 Month	N/A	N/A
3 Month	N/A	N/A
6 Month	N/A	N/A
1 Year	+0.17%	+0.17%

More News

Shareholder Investigation Alert: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies is Fair to Shareholders – FCSC, PRTO, ARTX, ROAN

November 01, 2019

Lifshitz & Miller LLP Announces Investigation of Arotech Corporation, Dova Pharmaceuticals, Inc., Highlands Bankshares, Inc., Progenics Pharmaceuticals, Inc., Proteon Therapeutics, Inc., Roan Resource

October 08, 2019

PRTO, ARTX Shareholder Investigation: Halper Sadeh LLP is Investigating Whether the Sale of These Companies is Fair to Shareholders – PRTO, ARTX

September 24, 2019

Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Arotech Corporation (NASDAQ: ARTX) on Behalf of Arotech Shareholders and Encourages Arotech Investors to Contact the Firm

September 23, 2019

SHAREHOLDER ALERT: WeissLaw LLP Investigates Arotech Corporation

September 23, 2019

AROTECH INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Arotech Corporation - ARTX

October 03, 2019

Rigrodsky & Long, P.A. Files Class Action Suit Against Arotech Corporation

November 18, 2019

VistaGen Therapeutics Announces Positive Meeting With FDA Regarding Pivotal Phase 3 Study Of PH94B For Acute Treatment Of Anxiety In Patients With Social Anxiety Disorder

July 23, 2020

VistaGen Therapeutics and EverInsight Therapeutics Enter Strategic Collaboration to Develop and Commercialize PH94B for Anxiety Disorders in Greater China, South Korea and Southeast Asia

June 25, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.